CRP and non-small cell lung carcinoma: The combined dNLR and CRP parameters that are derived from CBC and BBC could be a potential sensitive prognostic factor, helpful in selecting the subset of early-stage NSCLC patients who may require closer follow-up after SBRT and its combination with systemic therapies such as immunotherapy.